AI & Machine Learning Startups

NeuroHive develops digital health monitoring and precision livestock farming tools for farmers, combining veterinary expertise with software engineering to track animal health in real-time.

1 investor

Canadian diagnostics company developing an AI-assisted finger-prick blood test for concussion and mild traumatic brain injury.

1 investor

Neuromorphic develops hardware-agnostic control software for robots, letting operators deploy and manage them through everyday interfaces such as Slack, email, and phone. It targets wet labs and other physical industries that want to add robots with minimal setup.

1 investor

Neuron Industries builds Cortex, an AI-native industrial controller that replaces the traditional PLC, HMI, historian, and vendor IDE in a single device, letting controls engineers describe machine behavior in plain English and generate auditable real-time Python code. The platform serves industrial automation and controls-engineering teams working on machines, skids, retrofits, and production lines, with a built-in browser IDE, wiring discovery, robot control, on-device historian, and simulation-based testing.

1 investor

Neuronova builds a fully analog neuromorphic processor that performs always-on inference directly on sensor signals below 1 microwatt, moving intelligence into the sensing layer before digital processing. Starting with audio applications for wearables and smart devices, its chip and SDK target sensor makers and system builders across the broader sensor market.

1 investor

Neurons develops AI tools that analyze consumer behavior and visual performance to help businesses optimize customer experiences and marketing decisions. The company applies neuroscience research to provide recommendations for improving marketing effectiveness across various industries.

1 investor

Neuron Soundware develops AI and IoT-based solutions for predictive machinery maintenance using sound analysis, helping manufacturing and industrial customers prevent unscheduled production shutdowns and optimize maintenance planning.

1 investor

NeuroSensum applies neuroscience-based research methods — including EEG, virtual reality, eye tracking, reaction-time applications, and facial coding — combined with proprietary algorithms to measure consumer perception. It uses these tools to synthesize implicit and explicit data into insights that inform brand strategies.

1 investor

NeuroSky provides biofeedback and biometric assessment solutions that help companies optimize hiring decisions, identify employee training needs, and improve workforce productivity through data-driven insights on cognitive performance and employee capabilities.

1 investor

NeuroSmart develops technology that enables users to treat stress as a trainable skill through neuroscience-based approaches. The company is focused on digital health and behavioral wellness applications.

1 investor

Neurosom develops a wearable sleep therapy device called Sleep WISP that uses EEG monitoring and AI-driven electrical stimulation to improve deep sleep and reduce dementia risk. The system is designed for at-home use and targets patients seeking cognitive health and disease prevention.

1 investor

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS. Its lead candidate, NTRX-07, is a CB2 receptor agonist designed to reduce neuroinflammation and promote neuronal survival.

1 investor

NeuroTrainer offers a cognitive training system using virtual reality and neuroscience to improve mental performance skills for athletes and students. The platform is designed for coaches and educators to elevate cognitive abilities including focus, decision-making, reaction time, and situational awareness.

1 investor

NeuroTx develops AI-powered electroceutical and neurotechnology solutions that use neural decoding and non-invasive vagus nerve stimulation to support sleep quality, cognitive function, and metabolic health. The company integrates wearable devices, mobile applications, and machine learning to deliver personalized bio-signal-based interventions for consumers and patients.

1 investor

Neuroute is an AI-powered platform that accelerates clinical trial execution through patient recruitment, trial monitoring, and predictive analytics. It serves pharmaceutical companies and clinical research organizations conducting clinical trials.

1 investor

NeuroVirt provides mixed reality therapy software for stroke and neurorehabilitation, offering gamified exercises for upper and lower limb recovery in clinical and home settings with real-time motion tracking and clinician dashboards.

1 investor

NeuroZen develops AI-based neuroimaging and genetic tools to predict, quantify, and monitor Alzheimer's disease and neurodegeneration, using multimodal clinical, neuropsychological, MRI, PET, and genomic data. Its products include AlzgenAI (genomic risk prediction), MemoAI (tablet-based cognitive testing), and NeuroAI (MRI/APOE-based amyloid PET positivity prediction), aimed at physicians for clinical decision-making, with a focus on Korean and Asian dementia cohorts.

1 investor

Neutune builds infrastructure to establish content provenance for AI-generated and hybrid music, identifying which melodies, vocals, stems, and other components were used and who controls the rights to them. It aims to support rights identification, licensing, remuneration, and enforcement for artists, rights holders, and the music industry.

1 investor

Neuweb is an Australian AI video analytics company that delivers real-time monitoring and situational awareness solutions for retail, smart cities, traffic management, and critical infrastructure. The company's deep-learning platform helps organizations detect risks, prevent losses, and improve operational efficiency while maintaining data sovereignty and compliance with Australian privacy standards.

1 investor

Nevam provides a platform that visualizes the complete customer journey in real-time, combining journey mapping, data analytics, and AI agents to help marketing and business teams understand and optimize every customer touchpoint. The platform connects strategy to execution for enterprise organizations seeking cross-functional visibility and data-driven decision-making across the customer lifecycle.

1 investor

New Computer built Dot, an AI personal companion app designed to understand and assist individual users. The company announced it is winding down operations and the Dot product.

1 investor

New Life Minds develops technology combining healthcare, life sciences, synthetic biology, and machine learning, with a stated focus on advancing brain evolution.

1 investor

New North Ventures is a venture capital firm run by former company operators and government professionals that invests in startups operating at the intersection of national security and economic resilience. It focuses on dual-use technology across national security, AI, and deep tech, helping founders navigate the space between startups and government.

1 investor

New Sapience builds "sapiens," a deterministic machine intelligence based on world-model directed-graph knowledge structures rather than machine learning or symbolic AI, used to automate decision-making and monitoring for critical infrastructure. It targets mission-critical operations across CISA-defined critical infrastructure sectors, offering expert human-in-the-loop judgement plus quantum-secure communications.

1 investor